Trials / Not Yet Recruiting
Not Yet RecruitingNCT07412665
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
A Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Subjects With Advanced Solid Tumors.
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Beijing Geekgene Technology Co., LTD · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GK01 injection | Autologous tumor-reactive T cells injection |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2027-03-31
- Completion
- 2028-03-31
- First posted
- 2026-02-17
- Last updated
- 2026-02-17
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07412665. Inclusion in this directory is not an endorsement.